Copertina

Advancing Accurate Quantification of Protein‐Ligand Interactions: Differential Scanning Calorimetry as a Precision Screening Tool Using BCL‐2 as a Model System

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Bircan Dinc, Berna Dogan, Thomas Mavromoustakos, Serdar Durdağı
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	ChemMedChem
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Beyond Docking: A Multitier Computational Pipeline for USP7 Inhibitor Optimization
di: Ehsan Sayyah, et al.
Pubblicazione: (2025)

Developing Dynamic Structure‐Based Pharmacophore and ML‐Trained QSAR Models for the Discovery of Novel Resistance‐Free RET Tyrosine Kinase Inhibitors Through Extensive MD Trajectories and NRI Analysis
di: Ehsan Sayyah, et al.
Pubblicazione: (2024)

Ligand Screening and Discovery Using Cocktail Soaking and Automated Microcrystal Electron Diffraction
di: Jieye Lin, et al.
Pubblicazione: (2025)

Ligand‐Based Pharmacophore Modeling and Structure‐Based Virtual Screening for Identifying Potential Therapeutic Agents Targeting the SARS‐CoV‐2 Spike Protein‐ACE2 Receptor Interaction
di: Timoteo Delgado‐Maldonado, et al.
Pubblicazione: (2026)

An Effective Reaction‐Based Virtual Screening Method to Discover New CDK8 Ligands
di: Wei Chen, et al.
Pubblicazione: (2025)

Discovery and in vitro Evaluation of Novel Serotonin 5‐HT2A Receptor Ligands Identified Through Virtual Screening
di: Agata Zięba, et al.
Pubblicazione: (2024)

Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein‐Protein Interaction
di: Robert Obermann, et al.
Pubblicazione: (2024)

Protonation Effects in Protein‐Ligand Complexes – A Case Study of Endothiapepsin and Pepstatin A with Computational and Experimental Methods
di: Helge Vatheuer, et al.
Pubblicazione: (2025)

Exploration of the Anticancer Efficacy and In Silico Drug Screening Study of Fe(II) and Fe(III) Complexes of Schiff Base and Phenanthroline Ligand
di: Jansi Rani J, et al.
Pubblicazione: (2026)

Inhibition of the Clathrin Terminal Domain—Amphiphysin Protein–Protein Interaction. Probing the Pitstop 2 Aromatic Moiety
di: Kate Prichard, et al.
Pubblicazione: (2025)

Incubation of Amyloidogenic Peptides in Reverse Micelles Allow Active Control of Oligomer Size and Study of Protein–Protein Interactions
di: Han‐Wen Chang, et al.
Pubblicazione: (2024)

Effects of Cholesterol on the Breast Cancer Resistance Protein: Studies through the Synthesis and Biological Evaluation of Chemical Tools
di: Ingrid Fatima Zattoni, et al.
Pubblicazione: (2025)

Emergence of Quantum Dots as Innovative Tools for Early Diagnosis and Advanced Treatment of Breast Cancer
di: Diana Díaz‐García, et al.
Pubblicazione: (2024)

Front Cover: Inhibition of the Clathrin Terminal Domain—Amphiphysin Protein–Protein Interaction. Probing the Pitstop 2 Aromatic Moiety (ChemMedChem 16/2025)
di: Kate Prichard, et al.
Pubblicazione: (2025)

Discovery of ICOS‐Targeted Small Molecules Using Affinity Selection Mass Spectrometry Screening
di: Longfei Zhang, et al.
Pubblicazione: (2024)

Front Cover: Incubation of Amyloidogenic Peptides in Reverse Micelles Allow Active Control of Oligomer Size and Study of Protein–Protein Interactions (ChemMedChem 23/2024)
di: Han‐Wen Chang, et al.
Pubblicazione: (2024)

Development of Keap1‐Nrf2 Protein–Protein Interaction Inhibitor Activating Intracellular Nrf2 Based on the Naphthalene‐2‐acetamide Scaffold, and its Anti‐Inflammatory Effects
di: Daisuke Yasuda, et al.
Pubblicazione: (2025)

GDF15 Analogues Acting as GFRAL Ligands
di: Andrea Di Santo, et al.
Pubblicazione: (2025)

Exploring Synthesis Strategies and Interactions between MOFs and Drugs for Controlled Drug Loading and Release, Characterizing Interactions through Advanced Techniques
di: Lidia E. Chiñas‐Rojas, et al.
Pubblicazione: (2024)

Screening Methods for Cervical Cancer
di: Jingyan Li, et al.
Pubblicazione: (2024)

Towards Multitargeted Ligands as Pain Therapeutics: Dual Ligands of the Cavα2δ‐1 Subunit of Voltage‐Gated Calcium Channel and the μ‐Opioid Receptor
di: Anita Wegert, et al.
Pubblicazione: (2024)

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation
di: Jinmin Miao, et al.
Pubblicazione: (2024)

How to Find a Fragment: Methods for Screening and Validation in Fragment‐Based Drug Discovery
di: Tim Kirkman, et al.
Pubblicazione: (2024)

One‐Step Assembly of Homogeneous DAR4 ADCs via a Traceless Fc Ligand‐Directed Acylation Strategy
di: Yue Zeng, et al.
Pubblicazione: (2026)

Development of a NanoBRET Assay Platform to Detect Intracellular Ligands for the Chemokine Receptors CCR6 and CXCR1
di: Max E. Huber, et al.
Pubblicazione: (2024)

Investigating the Ligand‐Binding Properties of N‐arylbenzimidazoles as Novel Elastase Inhibitors
di: Giovanna Pitasi, et al.
Pubblicazione: (2025)

A Novel Triose Phosphate Isomerase Inhibitor With Dual Trypanosomicidal Activity was Identified Using Artificial Intelligence‐Based Virtual Screening
di: Elena Aguilera, et al.
Pubblicazione: (2026)

The Wheel of Fortune: Helical Wheel Alanine Scanning of a Spider Venom Antimicrobial Peptide Reveals Residues Involved in Antimicrobial and Cytotoxic Activity
di: Jomari C. Fernando, et al.
Pubblicazione: (2024)

Pinpointing Acidic Residues in Proteins
di: Weimin Xuan, et al.
Pubblicazione: (2024)

Native State Stabilization of Amyloidogenic Proteins by Kinetic Stabilizers: Inhibition of Protein Aggregation and Clinical Relevance
di: Priyanka, et al.
Pubblicazione: (2024)

Sertraline as a Scaffold for Antitrypanosoma Cruzi Drug Development: Design of Novel Derivatives and Computational Target Screening
di: Ali S. Mijoba, et al.
Pubblicazione: (2025)

Structure‐ and Ligand‐Based Discovery of Novel 3‐Chymotrypsin‐Like Protease Nonpeptidomimetic Hits
di: Sabrina Silva‐Mendonça, et al.
Pubblicazione: (2026)

Fluorescence Detection of DNA/RNA G‐Quadruplexes (G4s) by Twice‐as‐Smart Ligands
di: Jiri Ledvinka, et al.
Pubblicazione: (2025)

The Evaluation of Glyceryl C3‐Azolyl‐Thiogalactosides as Galectin‐1 and Galectin‐3 Ligands
di: Vít Prouza, et al.
Pubblicazione: (2025)

Ligand‐Induced Conformational Plasticity of the CTLH E3 Ligase Receptor GID4
di: Daria Kotlarek, et al.
Pubblicazione: (2026)

Cyclic Peptides Radiopharmaceuticals: A Concise Review of Ligand Identification, Radiolabeling, and Clinical Progress
di: Xiushuang Yuan, et al.
Pubblicazione: (2026)

Replacing a Cereblon Ligand by a DDB1 and CUL4 Associated Factor 11 (DCAF11) Recruiter Converts a Selective Histone Deacetylase 6 PROTAC into a Pan‐Degrader
di: Felix Feller, et al.
Pubblicazione: (2025)

Membrane Proteins in Nanodiscs: Methods and Applications
di: Jiaxu Guo, et al.
Pubblicazione: (2025)

Virtual and in Vitro Screening Employing a Repurposing Approach Reveal 13‐cis‐Retinoic Acid is a PTP1B Inhibitor
di: Reyna Del Carmen Navarrete‐Mondragón, et al.
Pubblicazione: (2024)

Towards the Targeted Protein Degradation of PRMT1
di: Poppy L. Martin, et al.
Pubblicazione: (2024)